Michael Robinson: This Week in Weed

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Daily Trade Alliance. Your ability to alter your subscription information can be found at the bottom of this email. [Trading and Investing Pros] [Live on camera: Learn how to become $2,918 richer in under a minute]( Thanks to his uncanny ability to beat the stock market's top traders, this man was paid $20 million to divulge almost all his secrets. He kept his most powerful secret quiet - but he's sharing it today, live on camera. [Watch him]( become $1,050 richer in 15 seconds... $940 richer in 11 seconds... $1,260 richer in 8 seconds... and $988 richer in 7 seconds! To see how easily this extra cash adds up, [go here](... --------------------------------------------------------------- July 14, 2018 Latest Research In the Media [D.R. Barton on Varney & Co]( [Watch the full video here.]( Not Even a Veto Could Stop This State's Efforts to End Prohibition By Michael Robinson Editor's Note: Today we're bringing you an urgent update from Michael Robinson. When it comes to technology and cannabis profits, he's the guy. As a leading analyst and tech journalist, he's been on the forefront of just about every emerging technology and marijuana story of the last decade. So when he recently shared some profitable insight with his readers, I just had to make sure we got it in front you too... Dear Reader, All this year, I've been following the efforts of citizens in more than a dozen states to legalize medical and/or recreational cannabis. Maine - because it's already fully legalized marijuana to some extent - wasn't even on my radar. But it should have been... Lawmakers there just overturned Republican Gov. Paul LePage's veto of a bill to expand the state's medical marijuana regime. While Maine's previous legislation limited medical marijuana's use, the new bill will allow physicians to prescribe cannabis for any medical reason. Here's what happened... Maine's House of Representatives overrode the veto in a resounding 119-23 earlier this week, while the state's Senate did so 25 to 8. The legislation also allows cannabis dispensaries to expand their operations, provides the state and municipalities with more decision-making ability to regulate cannabis businesses, and grants six new medical dispensary licenses. Not only that, but Maine lawmakers overrode LePage's veto on another cannabis-related bill. This one creates a new kind of license for medical cannabis extract companies that make edibles for patients who don't wish to smoke. This isn't the first time Maine lawmakers have pushed back against LePage's opposition to legal marijuana. In May, they resoundingly overrode his veto to stall the legal sale of recreational marijuana in the state, which voters approved via ballot initiative in November 2016. Recreational sales are slated to begin in the spring 2019, while the medical provisions that just passed will go into effect even sooner, within the 90 days. The Cannabis Business Times forecasts Maine's cannabis market size to reach $222 million in five years. So, this is a story worth following - and it's on me that I wasn't watching it more closely. [This tiny company is scheduled to disrupt every facet of the $3 trillion healthcare industry]( This marks a quantum-leap advancement on a revolutionary technology - one that's taking medicine, science, and Wall Street by storm. And it recently won a [spectacular patent verdict]( that could bring Big Pharma to its knees. MIT Tech Review says this device could completely replace antibiotics - a $45 billion global industry. [Click here to find out more.]( And, of course, it's great news for the cannabis-related companies I've shown you here - including GW Pharmaceuticals PLC ([Nasdaq ADR: GWPH](). That's the biotech firm that just received FDA approval to sell its cannabis-based childhood epilepsy treatment Epidiolex in the United States. But Maine is just the tip of the iceberg. This election year, I'm tracking cannabis legalization efforts in more than a dozen states. We've already seen what can happen when big changes in marijuana laws take place. In the election year of 2012, six states had legalization on the ballot, and select cannabis stocks soared 1,515%... 2,738%... 3,240% and more. In 2016, eight states had legalization on the ballot - and stocks soared as much as 12,400%. Can you even remember the last time you heard of a single stock that made anybody this much money? But it takes a steady hand, a knowledgeable guide like me, to show you which firms are most likely to see their stock prices soar. [And I've spotted those stocks](. In fact, I've dug up [four tiny cannabis companies]( positioned for a massive upward jolt thanks to all the legalization efforts this year. I'm talking about the kind of gains with the power to turn a small stake into a $100,000 payday. I've shared these stocks with my paid-up Nova-X Report members. And I want to share them with you, too. [Get all the details here](. Cheers and good investing, --------------------------------------------------------------- You May Have Missed... [Play This Casino Stock for a Quick Potential 100% Gain Right Now]( A unique chart pattern - one of the most profitable there is - just flashed for [this stock](, so we're setting up now to double our money (or better). The last time I traded this stock, it delivered a 390% gain for my subscribers. And right now there are [three big reasons I've got it targeted for fast profits](: Seasonality is actually in the market's favor in July, This sector has been driven down, but won't stay there (which is our favorite time to buy in), and the stock's chart pattern is showing an "island bottom" - a very profitable time to trade[. Find out which stock I'm recommending today](... [Shocking courthouse decision could spark potential 28,700% revenue surge]( A tiny tech company just won a [critical patent battle](... putting them directly at the heart of a remarkable medical technology Bloomberg calls, "the discovery of the Century... that could change the world." This company is now perfectly poised to DOMINATE the U.S. medical market - and slated for a projected $97 billion in royalties and licensing fees. If you hesitate, you could get locked out of the chance to benefit from a 28,700% sales surge. [Get the details now](. [D.R. Barton on Varney & Co: Before You Short Tesla, Consider This...]( Condemnations of Tesla are rampant. These range from accusations of problems with their manufacturing to warnings that they are "burning cash." But a [new development in the company]( has spurred confidence among investors, and the stock is now in the green. The company recently announced that it plans to expand overseas. It intends to build a plant in Shanghai, China, which has the capacity to support a production of 5 million cars annually. Elon Musk is in China right now putting together new plans for working on batteries and cars. Click below to hear more about it in this episode of Varney & Co., and [see what D.R. Barton has to say about the latest developments in the market](. --------------------------------------------------------------- You are receiving this e-mail at {EMAIL}, as a part of your free subscription to Daily Trade Alliance. Remove your email from this list: [Unsubscribe]( [Manage Your Email Preferences]( To cancel by mail or for any other subscription issues, write us at: Daily Trade Alliance | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 [Contact Customer Service]( Website: [( © 2018 Daily Trade Alliance All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Daily Trade Alliance. 1125 N Charles Street, Baltimore MD 21201.